Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 17, 2019Cardiovascular DiabetologyOpen Access

Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes

View Full Paper
Ask AI
Bookmark
Share

Authors

RCRuth L. ColemanChurchill HospitalCSCharles A.B. ScottChurchill HospitalZLZhihui LangCleveland Clinic

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Coleman et al. (2019) studied this question.

synapsesocial.com/papers/6aac9996e1bede24bd2238aahttps://doi.org/10.1186/s12933-019-0933-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes2016 · 7,640 citations
  2. 2Diabetes and its drivers: the largest epidemic in human history?2017 · 343 citations
  3. 3Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes2015 · 12,305 citations
  4. 4On the potential of acarbose to reduce cardiovascular disease2014 · 56 citations
  5. 5Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus2018 · 57 citations